NET pt & caregivers: Click below for a FREE Neuroendocrine Cancer Pt. Guide! Updated in 2022, this 80-page book is a fantastic resource to help you manage your diagnosis & covers tumor sites, func & non-func NETs, NET grade & stage, finding care & more: bit.ly/3JRQ5c9

May is National Cancer Research Month! NETRF is the leading global funder of NET research, investing $37.6M since 2005. Earlier this year, two NETRF-funded researchers were recognized for excellence and received awards @ENETS. Read more here: netrf.org/2024/03/18/net…

Our 2024 Virtual KNOW YOUR NETs Pt. Ed conference is July 20th. We are finalizing details & topics, so mark your calendars to join us for this popular patient ed event! Watch email & our social channels for reg. info. #NeuroendocrineTumor #NeuroendocrineCancer #patienteducation

Our Director of Patient Education Jessica Thomas, MSW, LCSW shares her advice for fostering emotional wellness and resilience in your #NET journey.

Dr. Christopher Heaphy from Boston U Chobanian & Avedisian School of Medicine discusses basic and translational #NET research in Providence, RI, at our NET Impact Patient Education Conference. #patienteducation #neuroendocrinecancer #neuroendocrinetumors #fundresearch #letstalkaboutNETs

Dr. Kimberly Perez from Dana-Farber discusses symptom management when dealing with #NETs

Dr. Heather Jacene from @danafarber presents 'Nuclear Medicine & PRRT - What's New?' at our NET Impact Patient Education Conference in Providence, RI #letstalkaboutNETs #neuroendocrinecancer #neuroendocrinetumors #PatientCare #patienteducation

Dr. Thomas Clancy from Dana-Farber discusses surgery and interventional radiation treatments for #NETs at our patient education conference in Providence, RI. #LetstalkaboutNETs #neuroendocrinecancer #patienteducation

Dr. Thor Halfdanarson from Mayo Clinic Comprehensive Cancer Center presents “NETs: What do we know?” #letstalkaboutNETs #neuroendocrinecancer #NeuroendocrineTumors #patienteducation

Our CEO ElyseG welcomes the NET community to our patient conference in Providence. Thanks to NANETS for their collaboration to share this space and support the #neuroendocrinecancer community! #LetstalkaboutNETs

In Providence, RI for NANETS mtg for HCPs & NET Research Foundation pt education event. Noticed the State Capitol building has “HOPE” as the cornerstone, a perfect metaphor for the NET patient journey

We are excited to spend today in Providence, RI, for our NET Impact Patient Education Conference. We couldn't hold these events without the support of our generous sponsors Wren Laboratories Novartis Curium Pharma Crinetics Pharmaceuticals, and TerSera Therapeutics, for whom we are most grateful!

A very special THANK YOU to our Providence, RI, NET Impact Patient Education Conference sponsors
Curium Pharma Crinetics Pharmaceuticals Wren Laboratories Novartis
and TerSera Therapeutics for their generous support, which allows us to bring the most up-to-date patient education to NET patients.

Great news for the NET community! The FDA has approved Lutathera® for pediatric patients aged 12 & older w/somatostatin receptor-positive GEP-NETs. This is first-ever therapy specifically for pediatric patients with GEP-NETs. Read more: novartis.com/news/media-rel….

We're thrilled to add Novartis to our impressive slate of generous NET Impact Patient Education Conference sponsors on May 4th! Thank you to these partners who help us provide critical NET patient education to patients & caregivers #NeuroendocrineCancer #letstalkaboutNETs

A very special THANK YOU to our Providence, RI, NET Impact Patient Education Conference sponsors Curium Pharma Crinetics Pharmaceuticals Wren Laboratories and TerSera Therapeutics for their generous support, which allows us to bring the most up-to-date patient education to NET patients.

We've recently refreshed our NETWise Podcast episode discussing NETs and Young Adults - you can listen here: netrf.org/podcast/netwis…
Thanks to Mark Lewis & Jaydira Del Rivero, MD, as well as the other experts who contributed to this episode.

We are thrilled to have Dana-Farber NET experts join us next month in Providence, RI for our NET Impact Patient Conference. Join us! Link below to register.